ProPhase Labs, Inc.

NasdaqCM:PRPH Stock Report

Market Cap: US$10.7m

ProPhase Labs Future Growth

Future criteria checks 5/6

ProPhase Labs is forecast to grow earnings and revenue by 77.4% and 86.3% per annum respectively while EPS is expected to grow by 44.4% per annum.

Key information

77.4%

Earnings growth rate

44.4%

EPS growth rate

Pharmaceuticals earnings growth19.9%
Revenue growth rate86.3%
Future return on equityn/a
Analyst coverage

Low

Last updated27 Aug 2024

Recent future growth updates

Recent updates

Investors Give ProPhase Labs, Inc. (NASDAQ:PRPH) Shares A 65% Hiding

Nov 09
Investors Give ProPhase Labs, Inc. (NASDAQ:PRPH) Shares A 65% Hiding

It's Down 65% But ProPhase Labs, Inc. (NASDAQ:PRPH) Could Be Riskier Than It Looks

Nov 09
It's Down 65% But ProPhase Labs, Inc. (NASDAQ:PRPH) Could Be Riskier Than It Looks

Market Cool On ProPhase Labs, Inc.'s (NASDAQ:PRPH) Revenues Pushing Shares 26% Lower

Jul 03
Market Cool On ProPhase Labs, Inc.'s (NASDAQ:PRPH) Revenues Pushing Shares 26% Lower

Does This Valuation Of ProPhase Labs, Inc. (NASDAQ:PRPH) Imply Investors Are Overpaying?

Mar 04
Does This Valuation Of ProPhase Labs, Inc. (NASDAQ:PRPH) Imply Investors Are Overpaying?

ProPhase Labs, Inc.'s (NASDAQ:PRPH) Business And Shares Still Trailing The Industry

Jan 09
ProPhase Labs, Inc.'s (NASDAQ:PRPH) Business And Shares Still Trailing The Industry

ProPhase Labs, Inc. (NASDAQ:PRPH) Shares Could Be 28% Above Their Intrinsic Value Estimate

Sep 21
ProPhase Labs, Inc. (NASDAQ:PRPH) Shares Could Be 28% Above Their Intrinsic Value Estimate

Here's Why ProPhase Labs (NASDAQ:PRPH) Can Afford Some Debt

Aug 11
Here's Why ProPhase Labs (NASDAQ:PRPH) Can Afford Some Debt

We Ran A Stock Scan For Earnings Growth And ProPhase Labs (NASDAQ:PRPH) Passed With Ease

Apr 07
We Ran A Stock Scan For Earnings Growth And ProPhase Labs (NASDAQ:PRPH) Passed With Ease

ProPhase Labs (NASDAQ:PRPH) Seems To Use Debt Quite Sensibly

Jan 24
ProPhase Labs (NASDAQ:PRPH) Seems To Use Debt Quite Sensibly

ProPhase Labs: Small Cap Stock With Strong Fundamentals And Growth Potential

Oct 13

ProPhase Labs Q2 2022 Earnings Preview

Aug 10

Earnings and Revenue Growth Forecasts

NasdaqCM:PRPH - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026956N/AN/A1
12/31/202550-16N/AN/A1
12/31/202415-24N/AN/A1
9/30/202413-28-17-14N/A
6/30/202418-26-18-15N/A
3/31/202429-24-21-17N/A
12/31/202344-17-15-11N/A
9/30/202363-10-14-10N/A
6/30/202379-4-6-3N/A
3/31/202394759N/A
12/31/2022123182529N/A
9/30/2022146312123N/A
6/30/2022131271315N/A
3/31/2022111181315N/A
12/31/2021796-18-14N/A
9/30/202139-5-21-16N/A
6/30/202133-2-16-11N/A
3/31/2021280-16-11N/A
12/31/202015-2-4-3N/A
9/30/202012-234N/A
6/30/202011-233N/A
3/31/20209-3-2-2N/A
12/31/201910-3-1-1N/A
9/30/201911-3-1-1N/A
6/30/201911-4-2-2N/A
3/31/201912-3-1-1N/A
12/31/201813-2-2-2N/A
9/30/201813-1-3-3N/A
6/30/201814-1N/A-2N/A
3/31/201813-1N/A-6N/A
12/31/201710-2N/A-3N/A
9/30/20176-3N/A-1N/A
6/30/20175-3N/A-1N/A
3/31/20174-3N/A2N/A
12/31/20164-4N/A0N/A
9/30/2016-6-3N/A-2N/A
6/30/2016-3-2N/A-4N/A
3/31/2016-2-2N/A-5N/A
12/31/20153-2N/A-3N/A
9/30/201521-3N/A-4N/A
6/30/201522-7N/A-3N/A
3/31/201522-8N/A-4N/A
12/31/201422-8N/A-3N/A
9/30/201423-7N/A-1N/A
6/30/201424-2N/A-1N/A
3/31/201424-1N/A0N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: PRPH is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).

Earnings vs Market: PRPH is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: PRPH is expected to become profitable in the next 3 years.

Revenue vs Market: PRPH's revenue (86.3% per year) is forecast to grow faster than the US market (9% per year).

High Growth Revenue: PRPH's revenue (86.3% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if PRPH's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/30 14:45
End of Day Share Price 2025/01/30 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ProPhase Labs, Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hunter DiamondDiamond Equity Research LLC